Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Prostate (Late Stage^), 2016-2020

All Races (includes Hispanic), Male, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 23.6 (23.5, 23.7) N/A 44,928 21.1
Alabama 6 18.6 (17.9, 19.3) 46 (44, 49) 578 15.7
Alaska 6 23.0 (20.7, 25.5) 32 (15, 44) 88 22.4
Arizona 6 17.5 (16.9, 18.0) 49 (46, 49) 798 22.8
Arkansas 6 20.5 (19.6, 21.5) 43 (36, 45) 383 18.2
California 3 24.1 (23.8, 24.4) 28 (23, 31) 5,168 25.0
Colorado 6 24.3 (23.5, 25.1) 27 (18, 32) 753 23.7
Connecticut 3 27.3 (26.3, 28.3) 10 (6, 18) 623 21.9
Delaware 6 21.9 (20.3, 23.7) 37 (24, 43) 141 16.9
District of Columbia 6 29.1 (26.4, 32.0) 6 (1, 21) 89 21.8
Florida 6 19.4 (19.1, 19.7) 44 (43, 46) 2,933 19.9
Georgia 3 24.0 (23.4, 24.6) 29 (22, 32) 1,347 17.5
Hawaii 3 27.2 (25.7, 28.8) 11 (5, 22) 258 27.2
Idaho 3 25.9 (24.5, 27.3) 18 (8, 29) 274 21.3
Illinois 3 27.1 (26.6, 27.7) 14 (8, 17) 2,036 23.4
Iowa 3 30.1 (29.0, 31.2) 3 (1, 8) 607 25.0
Kansas 6 21.2 (20.2, 22.2) 39 (33, 43) 373 18.3
Kentucky 3 21.1 (20.3, 21.9) 40 (35, 43) 571 19.0
Louisiana 3 28.3 (27.4, 29.3) 8 (4, 14) 786 20.6
Maine 6 24.4 (23.1, 25.9) 25 (15, 35) 250 24.4
Maryland 6 22.4 (21.7, 23.2) 34 (30, 39) 792 16.3
Massachusetts 3 27.0 (26.3, 27.7) 15 (8, 19) 1,144 23.5
Michigan 6 23.6 (23.0, 24.1) 30 (25, 34) 1,537 20.9
Minnesota 6 29.6 (28.8, 30.5) 4 (1, 8) 1,017 25.7
Mississippi 6 25.3 (24.2, 26.4) 21 (13, 30) 447 19.1
Missouri 6 22.6 (21.9, 23.3) 33 (30, 38) 878 23.5
Montana 6 29.0 (27.3, 30.8) 7 (1, 16) 221 21.6
Nebraska 6 27.5 (26.1, 28.9) 9 (5, 20) 321 22.2
New Hampshire 6 26.4 (24.9, 27.9) 16 (6, 27) 250 22.3
New Jersey 3 23.1 (22.5, 23.7) 31 (28, 36) 1,250 16.1
New Mexico 3 18.4 (17.4, 19.5) 47 (43, 49) 250 21.5
New York 3 26.1 (25.7, 26.5) 17 (13, 21) 3,057 19.8
North Carolina 6 24.3 (23.8, 24.9) 26 (20, 31) 1,500 19.1
North Dakota 6 29.5 (27.3, 32.0) 5 (1, 17) 133 23.8
Ohio 6 24.9 (24.4, 25.4) 23 (18, 28) 1,863 21.8
Oklahoma 6 18.8 (18.0, 19.6) 45 (43, 49) 441 18.8
Oregon 6 25.3 (24.4, 26.2) 20 (15, 29) 688 26.2
Pennsylvania 6 24.6 (24.2, 25.1) 24 (19, 29) 2,109 22.4
Puerto Rico 6 13.5 (12.7, 14.2) N/A 272 9.5
Rhode Island 6 25.1 (23.4, 26.9) 22 (9, 34) 171 21.8
South Carolina 6 21.4 (20.7, 22.1) 38 (33, 43) 704 19.2
South Dakota 6 27.1 (25.1, 29.2) 13 (3, 27) 151 21.6
Tennessee 6 22.3 (21.7, 23.0) 35 (31, 39) 930 19.1
Texas 3 21.0 (20.7, 21.4) 41 (36, 43) 2,992 20.3
Utah 3 25.4 (24.2, 26.6) 19 (11, 30) 354 21.4
Vermont 6 31.9 (29.6, 34.4) 1 (1, 8) 146 30.7
Virginia 6 20.7 (20.1, 21.3) 42 (37, 43) 1,032 19.8
Washington 5 27.1 (26.4, 27.9) 12 (7, 18) 1,195 26.3
West Virginia 6 17.9 (16.9, 19.0) 48 (44, 49) 229 17.7
Wisconsin 6 30.4 (29.6, 31.2) 2 (1, 7) 1,147 24.9
Wyoming 6 22.2 (20.1, 24.5) 36 (19, 45) 87 19.3
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 07/18/2024 4:25 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
3 Source: SEER November 2022 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top